2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Matrix-M: new trials by email Literature Review of Matrix-M trials Research Report on Matrix-M
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M R21, RH5.1, R78C - Malaria,Falciparum | Phase 2 | Active not recruiting | University of Oxford | 360 | 2025-12-15 | 2026-10-21 |
| Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults 10µg of R21 with 50µg Matrix-M1, 6µg of Pfs230D1-CRM197 + 10µg of R21 with 50µg Matrix-M1 single vial coformulation, RABIVAX-S - Prevention of Malaria Transmission and Clinical Malaria | Phase 2 | Active not recruiting | Serum Institute of India Pvt. Ltd. | 1200 | 2025-08-22 | 2026-07-08 |
Serum Institute of India Pvt. Ltd. (1) · University of Oxford (1)
Burkina Faso (1) · Mali (1)
Halidou Tinto (1)